| Vol. 10.16 – 29 April, 2021 |
| |
|
|
| Researchers found that pazopanib ameliorated acute lung injury (ALI) manifestations and reduced mortality in mouse ALI models and reduced edema in human lung transplantation recipients. [Science Translational Medicine] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists demonstrated that mice lacking src homology 2 domain–containing inositol 5-phosphatase 1 (SHIP-1) selectively in hematopoietic cells developed spontaneous type 2 like inflammation in the lung. [Scientific Reports] |
|
|
|
| To study the role of Tet methylcytosine dioxygenase 2 (TET2) in alveolar epithelial cells during fibrosis, rseearchers determined TET2 protein levels in the lungs of IPF patients and compared TET2 expression in alveolar epithelial cells of idiopathic pulmonary fibrosis patients and controls using publicly available data sets. [FASEB Journal] |
|
|
|
| Investigators developed and fully validated a liquid chromatography with tandem mass spectrometry (LC‐MS/MS) method for quantification of tigecycline in human lung epithelial cells and polymorphonuclear neutrophils. [Rapid Communications in Mass Spectrometry] |
| |
|
|
| Researchers investigated the effect of triptolide on the migration and invasion of non-small cell lung cancer cell lines. [Acta Pharmacologica Sinica] |
|
|
|
| The authors explored the regulatory role of E2F transcription factor-1 and underlying mechanism in non-small-cell lung cancer development. [Molecular Therapy-Oncolytics] |
|
|
|
| Scientists indicated that ALK inhibition triggered LC3B-independent macroautophagic flux in EML4-ALK+ cells to support cancer cell survival and clonogenic growth. [Scientific Reports] |
|
|
|
| Investigators established cancer stem‑like cells derived from large‑cell lung cancer cells, NCI‑H460 and H661, and revealed that Schisandrin B inhibited the viability of cancer stem‑like cells at concentrations of ≥40 µmol/l. [Oncology Reports] |
|
|
|
| Scientists revealed that the DnaJ heat shock protein family (HSP40) member C12 (DNAJC12) expression levels were significantly upregulated in lung cancer tissues compared with non‑cancer lung tissues. [International Journal of Molecular Medicine] |
|
|
|
|
| Pirfenidone is an anti-fibrotic drug with an anti-oxidant activity that can prevent lung injury during SARS-CoV-2 infection by blocking the maturation process of transforming growth factor-beta and enhancing the protective role of peroxisome proliferator-activated receptors. [Pharmacological Reports] |
|
|
|
| The authors elucidated the cellular and molecular mechanisms of nanoparticles for anti-proliferative and apoptotic effects on human lung cancer cells and compared them with commercial drug cisplatin. [Amb Express] |
|
|
|
|
| Vertex Pharmaceuticals, Inc. announced that the European Commission has granted approval of the label extension for KAFTRIO® in a combination regimen with ivacaftor for the treatment of cystic fibrosis in all patients ages 12 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. [Vertex Pharmaceuticals, Inc.] |
|
|
|
| Positive topline results from the Phase III MELODY trial showed nirsevimab reduced lower respiratory tract infections requiring medical attention due to respiratory syncytial virus in healthy preterm and term infants. [Nirsevimab, Inc. (Globenews wire, Inc.)] |
|
|
|
|
| July 12 – 15, 2021 Virtual |
|
|
|
|
|
| Helmholtz Zentrum München – Neuherberg (bei München), Germany |
|
|
|
| University of Chicago – Chicago, Illinois, United States |
|
|
|
| Thomas Jefferson University – Philadelphia, Pennsylvania, United States |
|
|
|
| United Therapeutics Corporation – Manchester, New Hampshire, United States |
|
|
|
| Brigham and Woman’s Hospital – Boston, Massachusetts, United States |
|
|
|
|